AMANDA WOODWORTH: Open Payments
NPI 1215284971 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 15 payments from 9 companies in 2025. Trend: 2023 $435 · 2024 $350 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $107 |
| Novo Nordisk Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Galderma Laboratories, L.P. | 1 | $27 |
| Azurity Pharmaceuticals, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: AIRSUPRA, DYSPORT, EDARBI, MOUNJARO, QULIPTA, BOTOX, NP Thyroid 60, Dexcom G6 Transmitter.
Industry payments across KS — which companies pay providers there.
